by Scott Larrivee | May 29, 2025 | Podcast
In this episode of Talk Radioisotopes, host Scott Larrivee sits down with Sigal Kalmanson, CEO and Co-Founder of Starget Pharma, an early-stage company at the forefront of precision oncology. Starget is redefining the way radiopharmaceuticals are discovered and...
by Scott Larrivee | May 16, 2025 | Podcast
In this episode, Milton Lönnroth, Co-Founder and CEO, shares how Atley Solutions is changing the game for astatine-211, a promising isotope in cancer therapy. Atley supports radiopharmaceutical companies and researchers by enabling the scalable production and labeling...
by Scott Larrivee | May 12, 2025 | News
Radiopharmaceutical experts and researchers to gather June 19-20 in New Orleans NEW ORLEANS – May 12, 2025 – The first-ever U.S.-based meeting of the World Astatine Community will take place June 19-20, 2025 at the Sheraton in downtown New Orleans. The event will...
by Scott Larrivee | May 12, 2025 | News
WEST VALLEY CITY, Utah – May 12, 2025 – Nusano, a physics company transforming the production of radioisotopes, today announced its Chief Product Officer, Kevin Haehl, will participate in a radioisotope supply chain panel discussion at the 21st Annual PEGS (Protein...
by Scott Larrivee | Apr 30, 2025 | Podcast
In this episode, host Scott Larrivee speaks with Dr. Luke Nordquist, a medical oncologist and Founder/CEO of XCancer, a globally recognized clinical research center. Dr. Nordquist shares the origin story of XCancer—born out of a desire to bring cutting-edge prostate...
